Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications - PubMed (original) (raw)

Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications

P Pietschmann et al. Diabetologia. 1988 Dec.

Abstract

Recent studies indicate that serum levels of osteocalcin, a 49-aminoacid bone matrix protein, are a biochemical marker of bone formation. In order to study bone metabolism in diabetes mellitus, in 28 patients with Type 1 (insulin-dependent) diabetes mellitus, in 38 patients with Type 2 (non-insulin-dependent) diabetes mellitus and two control groups, matched for Type 1 and Type 2 diabetic patients, respectively, serum levels of osteocalcin, parathyroid hormone and 25 hydroxy vitamin D were measured by radioimmunoassay. Whereas in Type 1 diabetic patients and control subjects serum levels of osteocalcin and 25 hydroxy vitamin D were not statistically different, serum osteocalcin and 25 hydroxy vitamin D levels were significantly decreased in Type 2 diabetic patients when compared with corresponding control subjects (p less than 0.03 and p less than 0.001, respectively). Independent of the type of diabetes, serum parathyroid hormone levels were comparable in diabetic patients and matched control subjects. Serum osteocalcin levels were significantly lower in Type 1 diabetic patients with retinopathy and/or proteinuria than in Type 1 diabetic patients without microangiopathy (p less than 0.05). Whereas serum parathyroid hormone levels in Type 2 diabetic patients with retinopathy and/or proteinuria were significantly increased (p less than 0.02), 25 hydroxy vitamin D levels were decreased (p less than 0.02) when compared with Type 2 diabetic patients without microangiopathy. Our data give evidence of a vitamin D deficiency and a decreased bone formation in patients with Type 2 diabetes mellitus. In Type 1 diabetes mellitus bone formation as reflected by serum osteocalcin levels is influenced by the presence or absence of microangiopathic complications.

PubMed Disclaimer

Similar articles

• Serum osteocalcin levels in type I diabetes mellitus.
  Paşaoğlu H, Kumandaş S, Keleştimur F. Paşaoğlu H, et al. Turk J Pediatr. 1995 Oct-Dec;37(4):323-9. Turk J Pediatr. 1995. PMID: 8560599
• Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
  Jehle PM, Jehle DR, Mohan S, Böhm BO. Jehle PM, et al. J Endocrinol. 1998 Nov;159(2):297-306. doi: 10.1677/joe.0.1590297. J Endocrinol. 1998. PMID: 9795371
• Evaluation of serum osteocalcin as an index of altered bone metabolism.
  Kruse K, Kracht U. Kruse K, et al. Eur J Pediatr. 1986 Apr;145(1-2):27-33. doi: 10.1007/BF00441848. Eur J Pediatr. 1986. PMID: 3015628
• Endocrine roles of vitamin K-dependent- osteocalcin in the relation between bone metabolism and metabolic disorders.
  Al-Suhaimi EA, Al-Jafary MA. Al-Suhaimi EA, et al. Rev Endocr Metab Disord. 2020 Mar;21(1):117-125. doi: 10.1007/s11154-019-09517-9. Rev Endocr Metab Disord. 2020. PMID: 31761961 Review.
• Diabetic macrovascular disease and serum lipids: is there a connection?
  Merrin PK, Feher MD, Elkeles RS. Merrin PK, et al. Diabet Med. 1992 Jan-Feb;9(1):9-14. doi: 10.1111/j.1464-5491.1992.tb01707.x. Diabet Med. 1992. PMID: 1551316 Review. No abstract available.

Cited by

• Investigating the Association between Diabetic Neuropathy and Vitamin D in Emirati Patients with Type 2 Diabetes Mellitus.
  Al Ali T, Ashfaq A, Saheb Sharif-Askari N, Abusnana S, Mussa BM. Al Ali T, et al. Cells. 2023 Jan 3;12(1):198. doi: 10.3390/cells12010198. Cells. 2023. PMID: 36611991 Free PMC article.
• Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.
  Tallon EM, Ebekozien O, Sanchez J, Staggs VS, Ferro D, McDonough R, Demeterco-Berggren C, Polsky S, Gomez P, Patel N, Prahalad P, Odugbesan O, Mathias P, Lee JM, Smith C, Shyu CR, Clements MA. Tallon EM, et al. Diabetes Res Clin Pract. 2022 Dec;194:110156. doi: 10.1016/j.diabres.2022.110156. Epub 2022 Nov 15. Diabetes Res Clin Pract. 2022. PMID: 36400172 Free PMC article.
• The Association between Vitamin D Hypovitaminosis and Cardiovascular Disease Risk in Saudi Diabetic Patients Type II.
  Alrefai AA, Elsalamony E, Fatani SH, Kasemy ZA, Fatani A, Mohamed Kamel HF. Alrefai AA, et al. Biochem Res Int. 2022 Sep 23;2022:6097864. doi: 10.1155/2022/6097864. eCollection 2022. Biochem Res Int. 2022. PMID: 36193546 Free PMC article.
• Meta-analysis of Diabetes Mellitus-Associated Differences in Bone Structure Assessed by High-Resolution Peripheral Quantitative Computed Tomography.
  Walle M, Whittier DE, Frost M, Müller R, Collins CJ. Walle M, et al. Curr Osteoporos Rep. 2022 Dec;20(6):398-409. doi: 10.1007/s11914-022-00755-6. Epub 2022 Oct 3. Curr Osteoporos Rep. 2022. PMID: 36190648 Free PMC article. Review.
• Hypovitaminosis D and the endocrine phenotype of COVID-19.
  Giustina A. Giustina A. Endocrine. 2021 Apr;72(1):1-11. doi: 10.1007/s12020-021-02671-8. Epub 2021 Mar 18. Endocrine. 2021. PMID: 33738708 Free PMC article. Review.

References

1. 1. Diabetes. 1986 Aug;35(8):911-5 - PubMed
2. 1. J Biol Chem. 1981 Dec 25;256(24):12760-6 - PubMed
3. 1. Diabetes. 1977 Dec;26(12):1130-5 - PubMed
4. 1. Am J Physiol. 1971 Jun;220(6):1717-23 - PubMed
5. 1. Can Med Assoc J. 1967 Jan 21;96(3):132-9 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information